The Integrated Translational Science Center (ITSC) is a partnership between SWOG, Cold Spring Harbor Laboratory (CSHL) and The Jackson Laboratory (JAX) with the goal of facilitating incorporation of translational science into NCTN clinical trials. The program funds an annual workshop as well as pilot grants.

SWOG ITSC Pilot Grants

The purpose of the SWOG ITSC Pilot Awards program is to stimulate collaborative translational research among CSHL, JAX and SWOG investigators with the objective of rapidly integrating promising preclinical approaches into ongoing and future clinical trials.

These awards support projects with a CSHL or JAX scientist as Co-PI in a true partnership with a SWOG investigator Co-PI, with the goal of using technology platforms available at CSHL and JAX to obtain preliminary data that can then be used as the basis for external grant proposals and/or the development of clinical protocols. Priority is given to pilot projects that either (1) address issues germane to ongoing or planned SWOG clinical trials; or (2) show potential for leading to a future clinical trial, especially in the area of personalized medicine.

Funding up to $100,000 in direct costs for one year are awarded for pilot projects. Support for these awards is provided by The Hope Foundation, U10CA180944, and funds from CSHL or JAX.

2018 Request for Applications

Letter of Intent due: July 31, 2018
Invitations issued for full proposals: August 17, 2018
Full application due: October 1, 2018
Award announcement: November 1, 2018
Award start: January 31, 2019


The annual workshop is held each summer at Jackson Laboratory or Cold Spring Harbor Laboratory to facilitate collaborative projects between basic scientists and SWOG investigators.

Integrated Translational Science Center Workshop

This interactive workshop includes short talks by clinical scientists to describe key problems in cancer medicine, posters describing available technology platforms, and one-on-one and group discussions to brainstorm project proposals. The goal is to identify projects that engage expertise and technology platforms available at CSHL and JAX to obtain preliminary data that can then be used as the basis for external grant applications and/or the development of clinical protocols.

Ten to 15 participants are selected based on nominations from SWOG member institutions. The primary selection criterion is a strong desire to become increasingly engaged in translational cancer research which integrates the modern laboratory and the cancer clinical trial process.

The 2018 workshop was held at the Jackson Laboratory, June 27-29.